In Honor of Lynn Waltz — A True Hero of the Myasthenia Gravis Community

It is with great sadness that the InfuCare Rx team announces the loss of a dear friend and patient, Lenora “Lynn” Waltz. We have been honored with the privilege of knowing and treating Lynn for more than fifteen years. Lynn was instrumental in starting a local Myasthenia Gravis (MG) support group near Pasadena, Maryland, which ultimately became the Myasthenia Gravis Foundation of America (MGFA). Lynn was a passionate, fearless, and tremendous advocate who was a source of strength for many newly diagnosed MG patients.
Read more

InfuCare Rx Selected as a Preferred Provider by Cigna’s eviCore healthcare for Specialty and Non-Specialty Infusion Services

ASTON, Pennsylvania, February 10, 2021 – InfuCare Rx, a leading nationwide specialty infusion provider in the treatment of acute and chronic conditions, announced this week their selection as a preferred provider in Cigna’s eviCore healthcare specialty pharmacy network. InfuCare Rx has been selected as a preferred provider based on its high quality clinical therapy management capabilities, national scope and real-time data driven outcomes reporting through its proprietary digital solution, InfuCare Rx Health. InfuCare Rx will provide a variety of specialty and non-specialty infusion services to Cigna members through eviCore healthcare. These services will include anti-infective therapy, bleeding disorders, immunoglobulin therapy (IV and subcutaneous), parenteral nutrition and specialty biologics effective February 1, 2021.
Read more